HARBINGER STRATEGIES, LLC

Lobbying for CSL BEHRING LLC · Biopharmaceutical company

Filing 4th Quarter - Termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

Lobbying activity 1

Health Issues

The PLASMA Act (H.R.1476/S.694): issues related to Part D and plasma-derived therapies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.